Articles with public access mandates - pål klepstadLearn more
Not available anywhere: 3
Classification of pain in cancer patients–a systematic literature review
AK Knudsen, N Aass, R Fainsinger, A Caraceni, P Klepstad, M Jordhøy, ...
Palliative medicine 23 (4), 295-308, 2009
Mandates: Canadian Institutes of Health Research
Opioid Switch Dosing in Chronic Cancer Pain: A Prospective Longitudinal Study
AK Wong, P Klepstad, JP Rubio, AA Somogyi, S Vogrin, B Le, J Philip
Journal of Palliative Medicine 27 (3), 388-393, 2024
Mandates: National Health and Medical Research Council, Australia
P025. Using the intensive care unit for bedside dressing changes for open abdomen is time-and staff-efficient.
A Seternes, S Fasting, P Klepstad, S Mo, T Dahl, M Björck, A Wibe
Anaesthesiology Intensive Therapy/Anestezjologia, Intensywna Terapia 49, 2017
Mandates: National Natural Science Foundation of China
Available somewhere: 24
Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic system
BJ Laird, S Kaasa, DC McMillan, MT Fallon, MJ Hjermstad, P Fayers, ...
Clinical Cancer Research 19 (19), 5456-5464, 2013
Mandates: US National Institutes of Health
Quality of life in patients with advanced cancer: differential association with performance status and systemic inflammatory response
BJA Laird, M Fallon, MJ Hjermstad, S Tuck, S Kaasa, P Klepstad, ...
Journal of Clinical Oncology 34 (23), 2769-2775, 2016
Mandates: Research Council of Norway
Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: an update
MAG Sprangers, MSY Thong, M Bartels, A Barsevick, J Ordoñana, Q Shi, ...
Quality of Life Research 23, 1997-2013, 2014
Mandates: US National Institutes of Health, Dutch Cancer Society
Human genetic variability contributes to postoperative morphine consumption
M De Gregori, L Diatchenko, PM Ingelmo, V Napolioni, P Klepstad, ...
The Journal of Pain 17 (5), 628-636, 2016
Mandates: Government of Italy
The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes
MAG Sprangers, JA Sloan, R Veenhoven, CS Cleeland, MY Halyard, ...
Twin Research and Human Genetics 12 (3), 301-311, 2009
Mandates: US National Institutes of Health
Confirming neuropathic pain in cancer patients: applying the NeuPSIG grading system in clinical practice and clinical research
MR Mulvey, R Rolke, P Klepstad, A Caraceni, M Fallon, L Colvin, B Laird, ...
Pain 155 (5), 859-863, 2014
Mandates: National Institute for Health Research, UK
Genetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS study
DT Barratt, B Bandak, P Klepstad, O Dale, S Kaasa, LL Christrup, J Tuke, ...
Pharmacogenetics and genomics 24 (4), 185-194, 2014
Mandates: National Health and Medical Research Council, Australia
Renal function and symptoms/adverse effects in opioid‐treated patients with cancer
GP Kurita, S Lundström, P Sjøgren, O Ekholm, L Christrup, A Davies, ...
Acta Anaesthesiologica Scandinavica 59 (8), 1049-1059, 2015
Mandates: Research Council of Norway
Genetic and non-genetic factors associated with constipation in cancer patients receiving opioids
EA Laugsand, F Skorpen, S Kaasa, R Sabatowski, F Strasser, P Fayers, ...
Clinical and translational gastroenterology 6 (6), e90, 2015
Mandates: Research Council of Norway
Innate immune signalling genetics of pain, cognitive dysfunction and sickness symptoms in cancer pain patients treated with transdermal fentanyl
DT Barratt, P Klepstad, O Dale, S Kaasa, AA Somogyi
PloS one 10 (9), e0137179, 2015
Mandates: National Health and Medical Research Council, Australia, Research Council of …
Influenza and associated co-infections in critically ill immunosuppressed patients
I Martin-Loeches, V Lemiale, P Geoghegan, MA McMahon, P Pickkers, ...
Critical Care 23, 1-10, 2019
Mandates: Health Research Board, Ireland
Sleep quality with WHO Step III opioid use for cancer pain
G Jakobsen, M Engstrøm, P Fayers, MJ Hjermstad, S Kaasa, M Kloke, ...
BMJ Supportive & Palliative Care 9 (3), 307-315, 2019
Mandates: Research Council of Norway
The rare Arg181Cys mutation in the μ opioid receptor can abolish opioid responses
F Skorpen, S von Hofacker, M Bjørngaard, AH Skogholt, O Dale, S Kaasa, ...
Acta Anaesthesiologica Scandinavica 60 (8), 1084-1091, 2016
Mandates: Research Council of Norway
Genetic variation and cognitive dysfunction in opioid‐treated patients with cancer
GP Kurita, O Ekholm, S Kaasa, P Klepstad, F Skorpen, P Sjøgren
Brain and Behavior 6 (7), e00471, 2016
Mandates: Research Council of Norway
Clinical and genetic factors related to cancer-induced bone pain and bone pain relief
E Scarpi, D Calistri, P Klepstad, S Kaasa, F Skorpen, R Habberstad, ...
The oncologist 19 (12), 1276-1283, 2014
Mandates: Research Council of Norway
Single-nucleotide polymorphisms in TAOK3 are associated with high opioid requirement for pain management in patients with advanced cancer admitted to a tertiary palliative care …
T Gutteridge, M Kumaran, S Ghosh, R Fainsinger, P Klepstad, Y Tarumi, ...
Journal of Pain and Symptom Management 56 (4), 560-566, 2018
Mandates: Canadian Institutes of Health Research
Identification of genetic polymorphisms modulating nausea and vomiting in two series of opioid-treated cancer patients
F Colombo, G Pintarelli, A Galvan, S Noci, O Corli, F Skorpen, P Klepstad, ...
Scientific Reports 10 (1), 542, 2020
Mandates: AIRC Foundation for Cancer Research in Italy
Publication and funding information is determined automatically by a computer program